Professional Overview

Stephen Sklarew is a seasoned executive currently serving as the Chief Executive Officer at Synaptiq, a position he has held since 2017. He is also the Cofounder of MIM, The Exercise Prescription Company, which he founded in 2018. His key expertise areas include technology and business strategy, product management, and leadership, with a strong focus on the tech industry.

Experience Summary

Current Role

As the CEO of Synaptiq, Stephen oversees the overall strategy and direction of the company. His key responsibilities include driving business growth, leading cross-functional teams, and making strategic decisions to drive innovation and success. Under his leadership, Synaptiq has experienced significant growth and expansion into new markets.

Career Progression

Stephen has a notable career trajectory, with previous roles including Advisor at Karotene Inc., VP of Product at Veelo, and Vice President Product Management at Sage. He has also held leadership positions at CircleBack, Inc., CEB, Etensity, Experient Technologies, and Ernst & Young. Throughout his career, Stephen has demonstrated a strong ability to drive business growth, lead high-performing teams, and develop innovative products and solutions.

Areas of Expertise

Stephen's areas of expertise include:
Industry-specific skills: technology and business strategy, product management, and leadership
Technical competencies: software development, product development, and technology strategy
* Leadership and management capabilities: cross-functional team leadership, strategic planning, and business growth

Professional Impact

Stephen has made significant contributions to the tech industry, including driving business growth, developing innovative products, and leading high-performing teams. His notable projects and initiatives have resulted in measurable achievements, including revenue growth and market expansion.

Conclusion

Stephen Sklarew is a highly experienced and accomplished executive with a strong track record of driving business growth and innovation. His current focus is on leading Synaptiq and MIM, The Exercise Prescription Company, to continued success and expansion. His value proposition lies in his unique combination of technical, business, and leadership expertise, making him a valuable asset to any organization.